Is a complete BCBA/ABBV research report available?

No complete published report is available for bcba/ABBV (BCBA/ABBV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

bcba/ABBV stock profile: metrics, valuation and analysis

Market cap	681.6T
Revenue (ttm)	95.4T
Net income (ttm)	9.3T
EPS (ttm)	ARS 5,244
P/E (trailing)	73.4x
P/E (forward)	16.8x
Dividend	ARS 607 (1.49%)
Volume	919

All BCBA/ABBV indicators

Market & fundamental data

Available fields

232

Groups with data

Currency

USD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	57,000
Employees Change	5,000%
Employees Change Percent	10
Enterprise value	ARS 778.9T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	ARBCOM4603M9
Last refreshed	2026-09-12
Market cap	ARS 681.6T
Price	ARS 41,020
Price currency	ARS
Rev Per Employee	1,673,471,210.53x
Sector	Healthcare
Sic	2836
Symbol	bcba/ABBV
Website	https://www.abbvie.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.36%
EV Earnings	83.85x
EV/EBIT	22.49x
EV/EBITDA	16.53x
EV/FCF	28.87x
EV/Sales	8x
FCF yield	3.96%
Forward P/E	16.83x
P/B ratio	-78.13x
P/E ratio	73.37x
P/S ratio	7.15x
PE Ratio10 Y	41.3x
PE Ratio3 Y	81.44x
PE Ratio5 Y	58.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	35.56%
EBITDA Margin	47.78%
FCF margin	27.7%
Gross margin	72.79%
Gross Profit	ARS 69.4T
Gross Profit Growth	12.78%
Gross Profit Growth Q	14.64%
Gross Profit Growth3 Y	5.88%
Gross Profit Growth5 Y	5.07%
Net Income	ARS 9.3T
Net Income Growth	67.69%
Net Income Growth Q	285.18%
Net Income Growth Qo Q	424.16%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-10.12%
Net Income Growth5 Y	-1.02%
Pretax Margin	13.51%
Profit Margin	9.8%
Profit Per Employee	ARS 163M
Profitable Quarters	ARS 6
Profitable Years	17
ROA	10.51
Roa5y	8.68
ROCE	24.49
Roe5y	1,295.2
ROIC	17.7
Roic5y	21.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	38.62%
Cagr3y	58.19%
Cagr5y	86.86%
Div CAGR3	100.71%
EPS Growth	68.54
EPS Growth Q	290.4
EPS Growth Qo Q	422.7
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-10.05
EPS Growth5 Y	-0.92
FCF Growth	-0.16%
FCF Growth Q	-36.24%
FCF Growth Qo Q	-12.63%
FCF Growth3 Y	-9.78%
FCF Growth5 Y	-1.43%
OCF Growth	1.16%
OCF Growth Q	-33.32%
OCF Growth Qo Q	-10.26%
OCF Growth10 Y	9.1%
OCF Growth3 Y	-8.59%
OCF Growth5 Y	-0.94%
Revenue Growth	10.39x
Revenue Growth Q	10.16x
Revenue Growth Qo Q	13.25x
Revenue Growth Quarters	10x
Revenue Growth Years	0x
Revenue Growth3 Y	4.75x
Revenue Growth5 Y	3.69x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 0.47
Assets	ARS 200.2T
Cash	ARS 9.7T
Current Assets	ARS 50.9T
Current Liabilities	ARS 63T
Debt	ARS 105T
Debt EBITDA	ARS 2.28
Debt FCF	ARS 3.89
Equity	ARS -8.7T
Interest Coverage	7.85
Liabilities	ARS 208.9T
Long Term Assets	ARS 149.2T
Long Term Liabilities	ARS 145.9T
Net Cash	ARS -95.3T
Net Cash By Market Cap	ARS -13.98
Net Debt EBITDA	ARS 2.09
Net Debt FCF	ARS 3.53
Tangible Book Value	ARS -134.2T
Tangible Book Value Per Share	ARS -75,953

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.81
Inventory Turnover	3.47
Net Working Capital	ARS -9.2T
Quick ratio	0.49
Working Capital	ARS -11.8T
Working Capital Turnover	ARS -10,324

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.03%
Dividend Growth	32.63%
Dividend Growth Years	4%
Dividend per share	ARS 607
Dividend Years	6
Dividend Yield	1.49%
Ex Div Date	2026-07-15
Last Dividend	ARS 161
Payout Frequency	Quarterly
Payout Ratio	189.83%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	38.59%
200-day SMA	34,882.2
3Y total return	296.01%
50-day SMA	40,383.2
50-day SMA vs 200-day SMA	50over200
5Y total return	2,176.98%
All Time High	43,000
All Time High Change	-4.33%
All Time High Date	2026-07-03
All Time Low	1,501
All Time Low Change	2,640.84%
All Time Low Date	2021-03-25
ATR	1,023.1
Ch YTD	18.15
High	41,480
High52	43,000
High52 Date	2026-07-03
High52ch	-4.6%
Low	40,920
Low52	28,420
Low52 Date	2025-10-27
Low52ch	44.34%
Ma50ch	1.87%
Price vs 200-day SMA	17.94%
RSI	52.87
RSI Monthly	75.04
RSI Weekly	62.47
Sharpe ratio	1.11x
Sharpe Ratio3y	1.44x
Sharpe Ratio5y	1.73x
Sortino ratio	1.85
Sortino Ratio3y	2.3
Sortino Ratio5y	2.74
Total Return	1.46%
Tr YTD	20.09
Tr1m	5.11%
Tr1w	-0.68%
Tr3m	21.89%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,763,985,547%
Net Borrowing	632,325,738,000
Shares Insiders	0.07%
Shares Institutions	76.62%
Shares Qo Q	-0.23%
Shares Yo Y	0.03%
Short Ratio	3.05

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS 25.5T
Adjusted OCF	27,453,676,500,000
Average Volume	1,088.55x
Bv Per Share	-4,975.9
CAPEX	ARS -1.9T
Ch1m	5.11
Ch1w	-0.68
Ch1y	35.78
Ch3m	21.07
Ch3y	274.1
Ch5y	1,996.8
Ch6m	24.07
Change	0.64%
Change From Open	-0.29
Close	40,760
Days Gap	0.93
Depreciation Amortization	11,903,758,929,000
Dollar Volume	37,697,380
Earnings Date	2026-10-29
EBIT	ARS 33.9T
EBITDA	ARS 45.6T
EPS	ARS 5,244
F Score	8
FCF	ARS 27T
FCF EV Yield	3.46x
Financing CF	-19,098,016,500,000
Fiscal Year End	December
Founded	2,012
Goodwill	53,731,047,579,000
Income Tax	ARS 3.5T
Investing CF	-9,626,787,000,000
Is Primary Listing	0
Last Earnings Date	2026-07-31
Last Report Date	2026-06-30
Lynch Fair Value	ARS 2,778
Lynch Upside	-93.19
Ma150	35,118.5
Ma150ch	17.15%
Ma20	41,226
Ma20ch	-0.21%
Net CF	151,113,000,000
Next Earnings Date	2026-10-29
Open	41,140
P FCF Ratio	25.26
P FCF Ratio SBC	26.69
P OCF Ratio	23.58
P OCF Ratio SBC	24.83
Payment Date	2026-08-14
Position In Range	17.86
Ppne	8,767,846,836,000
Price Date	2026-09-11
Price EBITDA	ARS 14.95
Relative Volume	0.84x
Revenue	95,387,859,000,000x
SBC By Revenue	1.52x
Share Based Comp	1,445,944,000,000
Tax By Revenue	3.7x
Tax Rate	27.39%
Tr6m	25.5%
Volume	919
Z Score	2.42

BCBA/ABBV (BCBA/ABBV)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/ABBV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/ABBV indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on BCBA/ABBV

Frequently asked questions